<DOC>
	<DOCNO>NCT00311753</DOCNO>
	<brief_summary>Acutely ill immobilize patient high risk thromboembolic event include deep venous thrombosis pulmonary embolism . Unfractionated heparin ( UFH ) low molecular weight heparin ( LMWH ) think effective prevent thromboembolic event . This study design provide efficacy safety data thromboprophylaxis LMWH certoparin comparison thromboprophylaxis UFH acutely ill non-surgical patient .</brief_summary>
	<brief_title>Efficacy Safety Low-molecular Weight Heparin Thromboprophylaxis Acutely Ill Medical Patients</brief_title>
	<detailed_description />
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Certoparin</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>Hospitalization due acute nonsurgical disease Significant decrease mobility Indication anticoagulant thrombolytic therapy Major surgical invasive procedure within 4 week precede randomization Expected major surgical invasive procedure ( include spinal/peridural/epidural anesthesia lumbar puncture ) within 2 week follow randomization Immobilization due cast fracture low extremity Immobilization lasting longer 3 day period prior randomization Heparin administration longer 36 hour period prior randomization Acute ischemic stroke Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>heparin , thromboprophylaxis , medical patient , acutely ill</keyword>
	<keyword>Acutely ill non surgical patient</keyword>
	<keyword>Immobilization</keyword>
</DOC>